• Galectin Therapeutics Chief Medical Officer Jamil Khurram exercised stock options for 7,557 shares at USD 1.23 on June 23, 2026.
• Khurram sold 7,557 shares the same day at a weighted average price of USD 3.14.
• He held 0 shares of common stock following the transactions.
• He reported 32,500 stock options remaining after the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001133416-26-000057), on June 25, 2026, and is solely responsible for the information contained therein.